Research Article
Analysis of the Bacterial Spectrum and Key Clinical Factors of Biliary Tract Infection in Patients with Malignant Obstructive Jaundice after PTCD
Table 2
Drug resistance of the main gram-negative bacteria.
| | Antibiotic | Escherichia coli (15 strains) | Klebsiella pneumoniae (12 strains) | Pseudomonas aeruginosa (6 strains) | | Drug-resistant strain () | Drug resistance rate | Drug-resistant strain () | Drug resistance rate | Drug-resistant strain () | Drug resistance rate |
| | Amikacin | 1 | 6.67% | 1 | 8.33% | 0 | 0.00% | | Aztreonam | 6 | 40.00% | 6 | 50.00% | 1 | 16.67% | | Ciprofloxacin | 8 | 53.33% | 7 | 58.33% | 1 | 16.67% | | Cefoperazone sulbactam | 1 | 6.67% | 3 | 25.00% | 0 | 0.00% | | Cefuroxime | 8 | 53.33% | 6 | 50.00% | — | — | | Cefepime | 3 | 20.00% | 5 | 41.67% | 0 | 0.00% | | Gentamicin | 6 | 40.00% | 4 | 33.33% | 0 | 0.00% | | Levofloxacin | 7 | 46.67% | 7 | 58.33% | 1 | 16.67% | | Paediatric compound sulfamethoxazole tablet | 8 | 53.33% | 4 | 33.33% | 5 | 83.33% | | Tobramycin | 4 | 26.67% | 3 | 25.00% | 0 | 0.00% | | Ampicillin | 14 | 93.33% | 12 | 100.00% | 5 | 83.33% | | Ceftazidime | 5 | 33.33% | 6 | 50.00% | 2 | 33.33% | | Ceftriaxone | 8 | 53.33% | 6 | 50.00% | 5 | 83.33% | | Cefotetan | 1 | 6.67% | 3 | 25.00% | 4 | 66.67% | | Cefazolin | 9 | 60.00% | 6 | 50.00% | 6 | 100.00% | | Imipenem | 1 | 6.67% | 3 | 25.00% | 4 | 66.67% | | Meropenem | 1 | 6.67% | 3 | 25.00% | 2 | 33.33% | | Ampicillin sulbactam | 10 | 66.67% | 6 | 50.00% | 5 | 83.33% | | Tigecycline | 0 | 0.00% | 2 | 16.67% | — | — | | Piperacillin tazobactam | 1 | 6.67% | 3 | 25.00% | 0 | 0.00% |
|
|
